BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng F, Miyazawa T, Kloepfer LA, Harris RC. ErbB4 deletion accelerates renal fibrosis following renal injury. Am J Physiol Renal Physiol 2018;314:F773-87. [PMID: 28724608 DOI: 10.1152/ajprenal.00260.2017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Z, Xu Y, Krügel U, Schaefer M, Grune T, Nürnberg B, Köhler MB, Gollasch M, Tsvetkov D, Markó L. In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome. Int J Mol Sci 2022;23:6870. [PMID: 35743312 DOI: 10.3390/ijms23126870] [Reference Citation Analysis]
2 Tsou PS, Palisoc PJ, Ali M, Khanna D, Sawalha AH. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin. Arthritis Rheumatol 2021;73:1501-13. [PMID: 33586346 DOI: 10.1002/art.41694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Harris RC. The epidermal growth factor receptor axis and kidney fibrosis. Curr Opin Nephrol Hypertens 2021;30:275-9. [PMID: 33767055 DOI: 10.1097/MNH.0000000000000696] [Reference Citation Analysis]
4 Hassan NME, Shehatou GSG, Kenawy HI, Said E. Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src/STAT-3/NF-κB signaling. Environ Toxicol Pharmacol 2021;84:103625. [PMID: 33617955 DOI: 10.1016/j.etap.2021.103625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hassan NME, Said E, Shehatou GSG. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Life Sci 2021;272:119241. [PMID: 33600861 DOI: 10.1016/j.lfs.2021.119241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sheng L, Bayliss G, Zhuang S. Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease. Front Pharmacol 2020;11:598910. [PMID: 33574751 DOI: 10.3389/fphar.2020.598910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sun J, Hao L, Shi H. Associations between the concentrations of CD68, TGF-β1, renal injury index and prognosis in glomerular diseases. Exp Ther Med 2020;20:56. [PMID: 32952646 DOI: 10.3892/etm.2020.9184] [Reference Citation Analysis]
8 Zhu T, Ma Z, Wang H, Jia X, Wu Y, Fu L, Li Z, Zhang C, Yu G. YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways. Mol Cell Biochem 2020;475:137-49. [PMID: 32813142 DOI: 10.1007/s11010-020-03866-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Gao L, Zhong X, Jin J, Li J, Meng XM. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression. Signal Transduct Target Ther 2020;5:9. [PMID: 32296020 DOI: 10.1038/s41392-020-0106-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
10 De Keulenaer GW, Feyen E, Dugaucquier L, Shakeri H, Shchendrygina A, Belenkov YN, Brink M, Vermeulen Z, Segers VFM. Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure. Circ: Heart Failure 2019;12. [DOI: 10.1161/circheartfailure.119.006288] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
11 Cury MFR, Olivares EQ, Garcias RC, Toledo GQ, Anselmo NA, Paskakulis LC, Botelho FFR, Carvalho NZ, Silva AAD, Agren C, Carlos CP. Inflammation and kidney injury attenuated by prior intake of Brazil nuts in the process of ischemia and reperfusion. J Bras Nefrol 2018;40:312-8. [PMID: 30118536 DOI: 10.1590/2175-8239-JBN-2018-0016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zeng F, Wang Y, Kloepfer LA, Wang S, Harris RC. ErbB4 deletion predisposes to development of metabolic syndrome in mice. Am J Physiol Endocrinol Metab 2018;315:E583-93. [PMID: 29944391 DOI: 10.1152/ajpendo.00166.2018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
13 Ji X, Wang H, Wu Z, Zhong X, Zhu M, Zhang Y, Tan R, Liu Y, Li J, Wang L. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling. Med Sci Monit 2018;24:1633-41. [PMID: 29555895 DOI: 10.12659/msm.909236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]